According to ophthalmologist Bradley Katz, PhD, the study’s lead author, vision issues are already a comorbidity related to diabetes. However, the GLP-1 medications might also be responsible for ...

A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.